Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NUVANT, MOBILC CARDIAC TELEMETRY

K-Number: K113372 · 2012-03-07

ApplicantCorventis, Inc.
Decision Date2012-03-07
Product CodeQYX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

NUVANT, MOBILC CARDIAC TELEMETRY is the device name listed in this FDA 510(k) record. The listed applicant is Corventis, Inc.. It received FDA 510(k) clearance on 2012-03-07 under 510(k) number K113372. The device is classified under product code QYX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NUVANT, MOBILC CARDIAC TELEMETRY?

NUVANT, MOBILC CARDIAC TELEMETRY is a medical device that received FDA 510(k) clearance on 2012-03-07. The listed applicant is Corventis, Inc.. The 510(k) number is K113372.

When did NUVANT, MOBILC CARDIAC TELEMETRY receive FDA 510(k) clearance?

NUVANT, MOBILC CARDIAC TELEMETRY received FDA 510(k) clearance on 2012-03-07, under 510(k) number K113372.

Who is the listed applicant for NUVANT, MOBILC CARDIAC TELEMETRY?

The FDA 510(k) record lists Corventis, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NUVANT, MOBILC CARDIAC TELEMETRY?

The FDA product code for NUVANT, MOBILC CARDIAC TELEMETRY is QYX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Corventis, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K113187AVIVO MOBILE PATIENT MANAGEMENTK111917NUVANT, MOBILE CARDIAC TELEMETRYK091971AVIVO MOBILE PATIENT MANAGEMENT SYSTEM, NUVANT MOBILE CARDIAC TELEMETRY (MCT) SYSTEMK090696NUVANT CARDIAC EVENT MONITORING SYSTEM; NUVANT MOBILE CARDIAC TELEMETRY SYSTEMK083287AVIVO MOBILE PATIENT MANAGEMENT SYSTEM

Related Devices (Code: QYX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K250793RhythmStar System (SL)RhythMedix, LLCK241179Rhythm Express Remote Cardiac Monitoring System (RX-1 mini)VivaQuant, Inc.K240653SmartCardia 7L Platform (MCT)Smartcardia SAK240029Zio AT® device (A100A1001)iRhythm Technologies, Inc.K233584RhythmStar SystemRhythMedix, LLCK162956NOWCARDIO SYSTEMContex International Technologies (Canada), Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑